Clinical Trials Browser

Neoplasm Metastasis × Immune Checkpoint Inhibitors × 1 year × Clear all

NCT07405086 2026-05-22

Morning Versus Afternoon Administration of Immunotherapy for the Treatment of Advanced or Metastatic Solid Tumors, The Knight SHIFT Study

DermatologicGastrointestinalGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lung Neoplasms, Melanoma, Neoplasm Metastasis

NCT06524570 2026-02-18

iFOCUS

Phase 1 Recruiting

24 enrolled

Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT07070479 2025-09-18

Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial

Phase 2 Recruiting

208 enrolled

Head & Neck

Nasopharyngeal Carcinoma, Neoplasm Metastasis, Recurrence

NCT06076135 2025-06-15

ILDR-01

Phase 2 Active not recruiting

16 enrolled

Tumor-Agnostic

Neoplasm Metastasis